<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
xmlns:rawvoice="http://www.rawvoice.com/rawvoiceRssModule/"
	>
<channel>
	<title>e-Patients Discover Unrecognized Side EffectsComments on: --</title>
	<atom:link href="http://e-patients.net/archives/2009/06/e-patients-discover-unrecognized-side-effects.html/feed" rel="self" type="application/rss+xml" />
	<link>http://e-patients.net/archives/2009/06/e-patients-discover-unrecognized-side-effects.html</link>
	<description>because health professionals can&#039;t do it alone</description>
	<lastBuildDate>Tue, 22 May 2012 03:29:30 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	
	<item>
		<title>By: Monique Landry</title>
		<link>http://e-patients.net/archives/2009/06/e-patients-discover-unrecognized-side-effects.html/comment-page-1#comment-43841</link>
		<dc:creator>Monique Landry</dc:creator>
		<pubDate>Sat, 11 Jul 2009 14:15:24 +0000</pubDate>
		<guid isPermaLink="false">http://e-patients.net/?p=2732#comment-43841</guid>
		<description>The last post today (July 11, 2009) mentions an MS e-patient community. I have a friend who, after more than a year, has  a doctor who&#039;s leaning toward a &quot;probable diagnosis.&quot; I think this community would help her with the uncertainty. How does she connect with this e-community? Thank you for any help you can offer.

ML</description>
		<content:encoded><![CDATA[<p>The last post today (July 11, 2009) mentions an MS e-patient community. I have a friend who, after more than a year, has  a doctor who&#8217;s leaning toward a &#8220;probable diagnosis.&#8221; I think this community would help her with the uncertainty. How does she connect with this e-community? Thank you for any help you can offer.</p>
<p>ML</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Judy Feder</title>
		<link>http://e-patients.net/archives/2009/06/e-patients-discover-unrecognized-side-effects.html/comment-page-1#comment-41710</link>
		<dc:creator>Judy Feder</dc:creator>
		<pubDate>Mon, 06 Jul 2009 14:05:07 +0000</pubDate>
		<guid isPermaLink="false">http://e-patients.net/?p=2732#comment-41710</guid>
		<description>Joe, thanks for this important post.  As a long-time e-patient, I&#039;ve known anecdotally that information on little-known side effects is one of the key pieces of wisdom patients seek and share with one another.  There&#039;s nothing scarier, when you have a serious medical condition, to experience a symptom that your healthcare providers can&#039;t explain. Your thoughts inevitably drift toward the worst possible outcome.  Having others corroborate your experience is invaluable.  I was able to test this intuition in a survey I did with Professors Andrea Meier and Bret Shaw earlier this year.  (We&#039;ll be presenting this paper at the Medicine 2.0 meeting in Toronto in September).  Across very diverse e-patient communities (cancer, MS and Marfan&#039;s Syndrome, information on side effects is the most frequently sought type of information, with almost 90% of respondents reporting that they look for this kind of information.  I haven&#039;t seen the statin survey you refer to, but if it&#039;s part of Dr. Beatrice Golomb&#039;s work, I know she has been a pioneer in this important effort.</description>
		<content:encoded><![CDATA[<p>Joe, thanks for this important post.  As a long-time e-patient, I&#8217;ve known anecdotally that information on little-known side effects is one of the key pieces of wisdom patients seek and share with one another.  There&#8217;s nothing scarier, when you have a serious medical condition, to experience a symptom that your healthcare providers can&#8217;t explain. Your thoughts inevitably drift toward the worst possible outcome.  Having others corroborate your experience is invaluable.  I was able to test this intuition in a survey I did with Professors Andrea Meier and Bret Shaw earlier this year.  (We&#8217;ll be presenting this paper at the Medicine 2.0 meeting in Toronto in September).  Across very diverse e-patient communities (cancer, MS and Marfan&#8217;s Syndrome, information on side effects is the most frequently sought type of information, with almost 90% of respondents reporting that they look for this kind of information.  I haven&#8217;t seen the statin survey you refer to, but if it&#8217;s part of Dr. Beatrice Golomb&#8217;s work, I know she has been a pioneer in this important effort.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: When Side Effects Are Dismissed &#171; Chronic Illness &#38; Pain Support</title>
		<link>http://e-patients.net/archives/2009/06/e-patients-discover-unrecognized-side-effects.html/comment-page-1#comment-39481</link>
		<dc:creator>When Side Effects Are Dismissed &#171; Chronic Illness &#38; Pain Support</dc:creator>
		<pubDate>Tue, 30 Jun 2009 03:04:51 +0000</pubDate>
		<guid isPermaLink="false">http://e-patients.net/?p=2732#comment-39481</guid>
		<description>[...] The post from e-patients.net stated last week week A Research Letter in the Archives of Internal Medicine (June 22, 2009) gives the results of a patient survey conducted on the patient site askapatient.com. Over the course of three months, 367 people responded; more than 50 percent reported muscle and joint pain with fatigue associated with bisphosphonate osteoporosis drugs. . . [...]</description>
		<content:encoded><![CDATA[<p>[...] The post from e-patients.net stated last week week A Research Letter in the Archives of Internal Medicine (June 22, 2009) gives the results of a patient survey conducted on the patient site askapatient.com. Over the course of three months, 367 people responded; more than 50 percent reported muscle and joint pain with fatigue associated with bisphosphonate osteoporosis drugs. . . [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: SusannahFox</title>
		<link>http://e-patients.net/archives/2009/06/e-patients-discover-unrecognized-side-effects.html/comment-page-1#comment-50108</link>
		<dc:creator>SusannahFox</dc:creator>
		<pubDate>Thu, 25 Jun 2009 22:47:26 +0000</pubDate>
		<guid isPermaLink="false">http://e-patients.net/?p=2732#comment-50108</guid>
		<description>&lt;span class=&quot;topsy_trackback_comment&quot;&gt;&lt;span class=&quot;topsy_twitter_username&quot;&gt;&lt;span class=&quot;topsy_trackback_content&quot;&gt;New post by @JoeGraedon &quot;e-Patients Discover Unrecognized Side Effects&quot; http://bit.ly/4mos5Q&lt;/span&gt;&lt;/span&gt;</description>
		<content:encoded><![CDATA[<p><span class="topsy_trackback_comment"><span class="topsy_twitter_username"><span class="topsy_trackback_content">New post by @JoeGraedon &#8220;e-Patients Discover Unrecognized Side Effects&#8221; <a href="http://bit.ly/4mos5Q" rel="nofollow">http://bit.ly/4mos5Q</a></span></span></span></p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Ben</title>
		<link>http://e-patients.net/archives/2009/06/e-patients-discover-unrecognized-side-effects.html/comment-page-1#comment-38789</link>
		<dc:creator>Ben</dc:creator>
		<pubDate>Thu, 25 Jun 2009 17:07:24 +0000</pubDate>
		<guid isPermaLink="false">http://e-patients.net/?p=2732#comment-38789</guid>
		<description>An interesting idea. There is always a trade-off though. When you are doing a clinical trial on a new drug, you have to balance the need for a representative sample with the desire to not expose patients to any potential harms associated with the new drug. 

Any well-designed clinical trial will include pain-scale metrics or other measurements to detect side-effects. The problem with asking patients to report on side-effects is that a properly-designed clinical trial should do this already, but may use a sample size too small to detect all problems, whereas once the drug is approved you can collect data on larger patient populations but it&#039;s already &quot;too late&quot; as the drug is available and in use...</description>
		<content:encoded><![CDATA[<p>An interesting idea. There is always a trade-off though. When you are doing a clinical trial on a new drug, you have to balance the need for a representative sample with the desire to not expose patients to any potential harms associated with the new drug. </p>
<p>Any well-designed clinical trial will include pain-scale metrics or other measurements to detect side-effects. The problem with asking patients to report on side-effects is that a properly-designed clinical trial should do this already, but may use a sample size too small to detect all problems, whereas once the drug is approved you can collect data on larger patient populations but it&#8217;s already &#8220;too late&#8221; as the drug is available and in use&#8230;</p>
]]></content:encoded>
	</item>
</channel>
</rss>

